Clinical tumor stage | Planning target volume dose to primary tumor | Planning target volume dose to uninvolved regional lymph nodes (elective) | Planning target volume dose to involved regional lymph nodes |
T1-2, N0 | 50.4 Gy in 28 fractions (1.8 Gy/fraction) | 42 Gy in 28 fractions (1.5 Gy/fraction) | |
T3-4, N0 | 54 Gy in 30 fractions (1.8 Gy/fraction) | 45 Gy in 30 fractions (1.5 Gy/fraction) | |
Node-positive, ≤3cm | 54 Gy in 30 fractions (1.8 Gy/fraction) | 50.4 Gy in 30 fractions (1.68 Gy/fraction) | |
Node-positive, >3 cm | 54 Gy in 30 fractions (1.8 Gy/fraction) | 54 Gy in 30 fractions (1.8 Gy/fraction) |
آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟